SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-03-015346
Filing Date
2003-04-30
Accepted
2003-04-30 12:05:40
Documents
3
Period of Report
2003-06-10
Effectiveness Date
2003-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2109583zdef14a.htm DEF 14A 123414
3 G794764.JPG g794764.jpg GRAPHIC 3445
4 G447841.JPG g447841.jpg GRAPHIC 37817
  Complete submission text file 0001047469-03-015346.txt   166322
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21481 | Film No.: 03671520
SIC: 2836 Biological Products, (No Diagnostic Substances)